Ordentlich Peter
Chief Scientific Officer
1 company
Insider Signal Score
66
StrongTrades Analyzed
6
12M Win Rate
83.3%
Avg 3M Return
+10.2%
Avg 12M Return
+9.9%
Ordentlich Peter is a Chief Scientific Officer at Syndax Pharmaceuticals Inc. Recent SEC Form 4 filings include 0 buys and 14 sells.
Holdings by Company
SNDXFeb 15, 2023
Current Shares0
Value-
Net Activity-118,953
Bought: 0Sold: 119.0K
Transaction History
Showing 8 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2023 | SNDX Syndax Pharmaceuticals Inc | Chief Scientific Officer | Sale+OE | 25,000 | $25.84 | $646,092.50 | -100% | -18.8% | -12.8% | |
| Feb 1, 2023 | SNDX Syndax Pharmaceuticals Inc | Chief Scientific Officer | Sell | 69 | $28.43 | $1,961.54 | -100% | -31.7% | -26.7% | |
| Dec 2, 2022 | SNDX Syndax Pharmaceuticals Inc | Chief Scientific Officer | Sale+OE | 25,000 | $25.04 | $626,024.60 | -96.9% | -3.8% | -33.9% | |
| Aug 24, 2022 | SNDX Syndax Pharmaceuticals Inc | Chief Scientific Officer | Sale+OE | 25,000 | $25.04 | $625,892.50 | -97.9% | -9.6% | -26.8% | |
| Feb 1, 2022 | SNDX Syndax Pharmaceuticals Inc | Chief Scientific Officer | Sell | 1,412 | $16.65 | $23,509.80 | -100% | +3.5% | +74.5% | |
| Nov 23, 2020 | SNDX Syndax Pharmaceuticals Inc | Chief Scientific Officer | Sale+OE | 29,972 | $23.16 | $694,121.36 | -42.5% | - | - | |
| Apr 3, 2018 | SNDX Syndax Pharmaceuticals Inc | Chief Scientific Officer | Sale+OE | 7,500 | $15.00 | $112,500.00 | -100% | - | - | |
| May 17, 2017 | SNDX Syndax Pharmaceuticals Inc | Chief Scientific Officer | Sale+OE | 5,000 | $15.00 | $75,000.00 | -100% | - | - |